Biobot Surgical

Singapore, Singapore · Founded 2007 · Privately Held (backing)

Developer of a robotic prostate biopsy and treatment system designed for improved clinical outcomes. Biobot Surgical is based in Singapore, Singapore and was founded in 2007. Its last reported valuation was $54.3 million in Mar 2024. It has raised $38.7 million.

Last reported valuation
$54.3M
Oct 2026
Priced at
—
Total raised
$38.7M
Last round
—

Who backs Biobot Surgical?

16 investors
InvestorType
ClavystBioOther
Andreas Handayanto—
Ang Tiam—
Astrid Hill Investment—
Chia Chee Ming—
Jia Yu Capital—
Kupa (Other Commercial Products)—
Mark Hong—
MicroPort Scientific—
PTSM holding—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biobot Surgical investors

16 investors are on record for Biobot Surgical, including ClavystBio, Andreas Handayanto, Ang Tiam and Astrid Hill Investment.

Free account
More of Biobot Surgical with a free account
  • ·The complete investor list: 16 names
  • ·Watch Biobot Surgical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Biobot Surgical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View